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Introduction
Alport syndrome is rare genetic disorder of the glomerulus in the kidneys that can
be X-linked, Autosomal recessive, or Autosomal dominant in nature. Clinical
manifestation includes hearing loss, hematuria, proteinuria, and hypertension
(Cheungpasitporn, Kaewpoowat, Suksaranjit, Kittanamongkolchai, Srivali,
Ungprasert, & Rangan, 2012). It is most common disease in males. A 24-hour
urine specimen is usually obtained to check for proteinuria and elevated
creatinine, which indicate acute renal failure (Cosgrove, 2012). A renal biopsy
and ultrasounds is used to confirm the diagnosis of Alport Syndrome. Patients
that are diagnosed with such disease require dialysis and referral to an
ophthalmology and audiology. The following poster will help in understanding
the signs and symptoms, pathophysiology, and nursing implication of Alport
syndrome based on information found in literature research.

Understanding Pathophysiology and its
Significance
The pathophysiology of AS is complex in nature. According to the information obtain
from Alport Syndrome Foundation website, the syndrome is caused by genetic
mutations that affect the glomeruli which are the microfiltration units inside the
kidney. The glomeruli contain GBM that allows filtration of blood through the
membrane. The normal structures of the GMB are replaced by scar tissue, leading to
failure in the filtration system causing kidney failure in the AS. Type IV collagen is a
major part of important tissue structures called basement membranes that are present
in the kidneys. These proteins spread and result in GBM thickening and impairment of
selectivity with subsequent glomerular sclerosis, interstitial fibrosis, and renal failure.
Type IV collagen comes from a family of six proteins know as alpha-1 through alpha-6.
Mutation in alpha-3, alpha4, and alpha-5 chains cause Alport syndrome. X-linked AS is
the most common form that accounts for 80% to 85% of the cases and results from
mutations of the alpha-5 chain type IV collagen found inside gene COL4A5 (Rheault,
2012). Autosomal Recessive AS accounts for 10% to 15% of the cases and is caused by
mutation in the alpha-3 or alpha 4 chains found in COL4A3 or COL4A4 genes. Finally,
the rare cases of autosomal dominant AS is due to heterozygous transformation in
COL4A3 or COL4A4 also occur in 5% of cases (Bassareo. Marras, & Mercuro, 2010).

Signs and Symptoms

Implication for Nursing Care
Nurses play an important role in secondary and tertiary prevention against AS. Institute for
Work and Health states that the goal of secondary prevention is to slow the progress of disease in its earliest
stages (2014). Nurses need to continue encourage patients with the family history of AS to have regular exams
and screening tests to prevent complication from such disease. They educate patient about the importance of
blood pressure management to prevent further complication. They educate patient about diet, limiting fluids,
and other treatments options. They perform counseling and education to increase coping skills among patient
with such disease. At dialysis center, nurses assist physician in performing hemodialysis and peritoneal
dialysis on patient with renal failure secondary to AS. Nurses also can help patients in learning new skills such
as lip reading or sign language and getting hearing aids. They teach younger men with Alport syndrome the
importance of using hearing protection in noisy environments.
Finally, the goal of tertiary prevention is to prevent further physical deterioration and maximize
quality of life (Institute for Work and Health, 2014). It focuses on helping people manage complicated health
problem such as hearing loss, blindness, and kidney failure secondary to AS. Nurses assist patients with AS by
providing information about support groups such as Alport Syndrome Foundation and National Organization
for Rear Disorders. They also provide education about lifestyle modifications including diet, medication
administration and other preventive measure for patients undergoing kidney transplant secondary to end
stage kidney failure. Some trained nurses also provide genetic counseling to the patient with AS because the
disorder is inherited. They also AS patient with rehabilitation program and setting up patient support groups.
Assist

Conclusion
The content of this poster helped in identifying the common signs and symptoms of AS, pathophysiology, and
its implication to nursing care. The disease is more common among man and can be diagnosed as early at 2
years old. This genetic disorder not only affects the kidney, but also their vision, and hearing leading to end
stage renal failure, hearing loss, and blindness. It is important to provide patients with AS secondary and
tertiary prevention methods to manage complications from such genetic disorder. Through early screening
using genetic test can help in detecting this disease and can protect these patient from developing complication
and injury. The evaluation can also be made using blood test, urine test, ultrasound, and kidney biopsy
(Kashtan, Ding, Gregory, Gross, Heidet, Knebelmann, & Licht, 2013).

According to National kidney Foundation (NHF) patients with AS
symptoms may include: blood in the urine (hematuria), protein in the
urine (proteinuria), and high blood pressure (hypertension). It causes
damage to the kidney through scar formation in the glomerular basement
membrane (GBM) of a normal kidney structures. Studies published by
NHF also shows that 80% of boys with X-linked Alport syndrome
develops hearing loss at some point in their lives. Both gender with
autosomal recessive AS typically have childhood hearing loss and their
parents develop hearing loss at a later stage. Finally studies published by
NHF shows that, people with AS also have slow decline of vision, which
may lead to cataract formation and corneal erosion if left untreated. Some
people with this disease have abnormal pigment of the retina called dotand-fleck retinopathy. Alport syndrome may also results in the swelling of
legs, ankle, feet, and around the eyes (Iijima, Nozu, Kamei, Nakayama, Ito,
Matsuoka & Matsuo, 2010).

There is no specific treatment available against AS. People with such disease are treated symptomatically.
Kidney transplantation has showed some success in-patient with end-sate kidney failure. Medical researchers
are constantly working hard on understanding why people develop such disease and its treatments. Several
laboratory tests are being conducted on animals with AS to find the best treatment. (Temme, Kramer, Jager,
Lange, Peters, Müller, & Gross, 2012). Overall the joint effort among nurses and other healthcare providers can
help patient with AS to manage their disease.
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